Views | |
---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 67 |
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 0 | 1 | 2 | 1 | 1 | 10 | 1 |
Views | |
---|---|
2019_Ertaş_etal.pdf | 151 |
2019_Ertaş_etal.pdf | 6 |